Last reviewed · How we verify
Sequential Therapy of Atorvastatin Improving Tissue Reperfusion and Clinical Outcomes of ST-elevated Acute Myocardial Infarction Study（The STRAIT Study）
Statins have been approved to benefit patients underwent percutaneous coronary intervention (PCI). The current study is designed to evaluate the effectiveness and safety of Sequential Therapy of Atorvastatin in patients with ST-elevated myocardial infarction and receive PCI treatment.
Details
| Lead sponsor | Zhang Qi, MD |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 1200 |
| Start date | 2013-01 |
| Completion | 2017-02 |
Conditions
- Acute Myocardial Infarction
Interventions
- Sequential therapy of atorvastatin
Primary outcomes
- Major Adverse Events (MACE) Occourance Rate — 30 days
1. Cardiac Death (CD) 2. Non-fatal re-inarction (CK-MB, cTNI or cTNT elevation again and over 3 times higher than up normal limit accompanied with syptoms or EKG indication) 3. revascularization driven by syptoms (CABG or re-PCI)
Countries
China